publication venue for
- Subclinical atherosclerosis in adolescents and young adults and the risk of cardiovascular disease: The Strong Heart Family Study (SHFS).. 32. 2022
- The effectiveness of a structured group education programme for people with established type 2 diabetes in a multi-ethnic population in primary care: A cluster randomised trial.. 32. 2022
- Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?. 29. 2019
- Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network.. 29. 2018
- Adipose tissue palmitoleic acid is inversely associated with nonfatal acute myocardial infarction in Costa Rican adults.. 28. 2018
- Is increased uric acid a risk factor or a defensive response? The Campania Salute Network.. 28. 2018
- A new index to simplify the screening of hypertension in overweight or obese youth.. 27. 2017
- Type of myocardial infarction presentation in patients with chronic kidney disease.. 25. 2014
- Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity.. 24. 2014
- Heritability of arterial stiffness and carotid intima-media thickness: an Italian twin study.. 24. 2013
- Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the Strong Heart Study.. 24. 2013
- Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.. 23. 2013
- Dietary patterns and their association with cardiovascular risk factors in a population undergoing lifestyle changes: The Strong Heart Study.. 23. 2012
- Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.. 23. 2011
- Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.. 23. 2011
- Partial normalization of components of metabolic syndrome does not influence prevalent echocardiographic abnormalities: the HyperGEN study.. 23. 2011
- Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: the AREA-in-CHF study.. 21. 2010
- Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos.. 20. 2009
- Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study.. 19. 2009
- Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study.. 19. 2009
- Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.. 19. 2008
- Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.. 15. 2005
- Relation of insulin resistance to markers of preclinical cardiovascular disease: the Strong Heart Study.. 13. 2003
- Left ventricular geometry and arterial function in hypercholesterolemia.. 11. 2001
- Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines.. 24. 2014
- Sibutramine: balancing weight loss benefit and possible cardiovascular risk.. 18. 2008
- State of the heart in the metabolic syndrome.. 15. 2005
- Left ventricular geometry in obesity: Is it what we expect? 2013
- Obesity, heart failure and sudden death. 2002
- Current cardiovascular outcomes trials in type 2 diabetes: Perspectives and insight. 2016